Armata Pharmaceuticals, Inc. Common Stock (ARMP)
SG&A Expenses
$5.24M
Quarterly · Period ending: · USD
ARMP SG&A Expenses
Latest reported$5.24Mperiod ending
Latest reported$5.24Mperiod ending
ARMP Quarterly SG&A Expenses ($0.00 → $5.24M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ARMP sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 5,236,000 | |
| 3,463,000 | |
| 3,426,000 | |
| 3,111,000 | |
| 2,619,000 | |
| 3,253,000 | |
| 3,323,000 | |
| 3,244,000 | |
| 3,439,000 | |
| 3,178,000 | |
| 3,179,000 | |
| 3,362,000 | |
| 2,150,000 | |
| 2,538,000 | |
| 1,810,000 | |
| 1,561,000 | |
| 2,083,000 | |
| 1,983,000 | |
| 2,223,000 | |
| 1,768,000 | |
| 2,139,000 | |
| 2,151,000 | |
| 1,977,000 | |
| 1,845,000 | |
| 1,973,000 | |
| 2,171,000 | |
| 1,743,000 | |
| 3,758,000 | |
| 2,082,000 | |
| 1,380,000 | |
| 1,475,000 | |
| 1,276,000 | |
| 1,360,000 | |
| 1,591,000 | |
| 1,295,000 | |
| 1,613,000 | |
| 2,784,000 | |
| 1,898,000 | |
| 1,537,000 | |
| 1,781,000 | |
| 2,451,000 | |
| 2,644,000 | |
| 1,853,000 | |
| 1,843,000 | |
| 1,617,000 | |
| 1,397,000 | |
| -23,000 | |
| 1,701,000 | |
| 2,151,000 | |
| 1,627,000 | |
| 4,037,000 | |
| 1,215,000 | |
| 2,843,000 | |
| 714,000 | |
| 1,352,000 | |
| 1,036,000 | |
| 1,361,000 | |
| 957,000 | |
| 1,224,000 | |
| 1,752,000 | |
| 1,889,000 | |
| 2,208,000 | |
| 1,694,000 | |
| 1,575,000 | |
| 1,552,000 | |
| 1,646,000 | |
| 1,687,000 | |
| 1,568,000 | |
| 1,481,000 | |
| 1,278,000 | |
| 1,490,000 | |
| 1,660,000 | |
| 1,885,000 | |
| 1,358,000 | |
| 1,476,000 | |
| 2,066,000 | |
| 1,750,000 | |
| 1,583,000 | |
| 1,133,000 | |
| 1,438,000 | |
| 1,336,000 | |
| 3,613,000 | |
| 1,222,000 | |
| 1,579,000 | |
| 2,395,000 | |
| 1,266,000 | |
| 1,468,000 | |
| 1,442,000 | |
| 2,027,000 | |
| 2,390,000 | |
| 1,119,000 | |
| 1,092,000 | |
| 1,107,000 | |
| -2,000,000 | |
| 1,000,000 | |
| 700,000 | |
| 800,000 | |
| 900,000 | |
| 700,000 | |
| 700,000 |